These five stocks are trading under the $10 level and have big upside to the analyst's price targets. They could prove exciting additions to portfolios looking for solid alpha...
Learn about the marijuana stocks listed on the Nasdaq.
Hint: It has nothing to do with Canada's legalization of recreational marijuana.
Legalization of cannabis has been at the forefront of the news as both a social and medical issue for the past few years. The issues are complex, and many countries have held...
INSYS Therapeutics, Inc. (NASDAQ:INSY) announced that an FDA advisory committee voted against the approval of its lead pipeline candidate, buprenorphine sublingual spray, for the...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Strong Sell||Sell||Sell|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Sell|
|Summary||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Three Outside Up||1M||1||Sep 18|
|Three Outside Down||1W||1||Oct 07, 2018|
|Morning Doji Star||1D||1||Oct 12, 2018|
|Engulfing Bearish||1W||2||Sep 30, 2018|
|Upside Gap Three Methods||1W||2||Sep 30, 2018|
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. The Company develops and commercializes supportive care products. The Company's product Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients and a single-use product that delivers fentanyl, an opioid analgesic, for transmucosal absorption underneath the tongue. The Company markets Subsys through its field sales force focused on supportive care physicians in the United States. Subsys delivers a liquid fentanyl formulation in approximately 100, 200, 400, 600, 800, 1,200 and 1,600 micrograms (mcg) dosages. The Company's lead dronabinol product candidate is Syndros, which is under review for approval at the Food and Drug Administration. In addition, the Company is evaluating sublingual spray, inhaled and intravenous formulations of dronabinol in preclinical studies.Read More
|U.S. Commodity Futures Trading Commission (United States)||$250||Start Trading|
|National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States)||$2000||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.